Brief: Erasca Announces Clinical Trial Collaboration And Supply Agreement With Pierre Fabre To Evaluate Eras-007 And Encorafenib Combination
30/11/2022 14:38
Nov 30 (Reuters) - Erasca Inc ERAS.O :
* ERASCA ANNOUNCES CLINICAL TRIAL COLLABORATION AND SUPPLY
AGREEMENT WITH PIERRE FABRE TO EVALUATE ERAS-007 AND ENCORAFENIB
COMBINATION
* ERASCA INC - ERASCA WILL SPONSOR TRIAL
* ERASCA INC - PIERRE FABRE WILL SUPPLY ENCORAFENIB IN
PIERRE
FABRE TERRITORIES WHICH INCLUDE EUROPE AND ASIA PACIFIC
(EXCLUDING JAPAN AND SOUTH KOREA)
Source text for Eikon: ID:nGNX6Hf9Rc
Further company coverage: ERAS.O
((Reuters.Briefs@thomsonreuters.com;;))